• Foretinib: Translational Logic for Metastasis Research

  2026-08-24

  Foretinib (GSK1363089) offers translational researchers a way to connect Met- and VEGFR-driven signaling with proliferation, motility, invasion, and metastasis. This thought-leadership guide frames the compound as a mechanistic probe, explains how to separate growth arrest from cell death, and proposes an evidence-aware workflow for advancing from cell assays to cancer metastasis models.

• Amikacin Sulfate Workflows for NTM Research

  2026-08-24

  Amikacin Sulfate supports a practical bridge from intracellular NTM assays to granuloma-focused in vivo studies, with dose-response, CFU, uptake, and tissue-distribution readouts aligned in one workflow. This guide shows how to benchmark free drug, troubleshoot conflicting MIC results, and interpret targeted-delivery experiments without overextending evidence from unrelated resistance models.

• Proteinase K: A Translational Control Point in Proteomics

  2026-08-23

  Proteinase K is more than a routine DNA-preparation reagent: its broad substrate tolerance, inhibitor resistance, and compatibility with challenging buffers make it a powerful control for translational workflows. This article connects its molecular biology role to protease-selectivity research, including the reported discrimination between SARS-CoV-2 3CLpro and Proteinase K by merbromin.

• Foretinib (GSK1363089): Mechanism & Assay Guide

  2026-08-22

  Foretinib, also called GSK1363089, is an ATP-competitive multikinase inhibitor with nanomolar activity against Met and VEGFR-family kinases. This guide connects its biochemical potency with cell motility, tumor growth, metastasis, formulation, and viability-assay interpretation.

• Anlotinib hydrochloride: Anti-Angiogenic Workflows

  2026-08-22

  Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor for connecting VEGFR2, PDGFRβ, and FGFR1 blockade with measurable endothelial phenotypes. This practical guide covers migration, tube formation, ERK readouts, comparative assay design, and troubleshooting for cancer research.

• Baicalein for Reproducible Cell Assays

  2026-08-21

  Learn how Baicalein (SKU N1858) can be integrated into cell viability, proliferation, and cytotoxicity workflows with controlled solvent exposure, transparent concentration calculations, and orthogonal validation. The guide distinguishes product-supported handling data from exploratory assay recommendations and clarifies how to interpret pathway-level conclusions.

• Hypertension, DNA Damage, and Atrial Fibrillation

  2026-08-20

  The reference study identifies excessive DNA damage response, centered on ATM/CHK2/p53 signaling, as a mechanistic link between persistent hypertension and atrial electrical and structural remodeling. By combining human samples, spontaneously hypertensive rats, and Angiotensin II-challenged HL-1 cells, it also shows that pharmacological ATM inhibition can reduce associated autophagy, inflammation, and remodeling signals.

• hCG–EZH2–CXCL10 Signaling in Human Decidua

  2026-08-20

  The reference study identifies a hormone–chromatin–chemokine pathway in which human chorionic gonadotropin suppresses CXCL10 in human decidual stromal cells through EZH2-dependent H3K27me3 deposition. Its combination of primary cell models, promoter-focused chromatin analysis, and CD8-cell recruitment assays shows how epigenetic regulation can shape immune tolerance at the maternal–fetal interface.

• Ellagic Acid: A CK2 Assay Decision Framework

  2026-08-19

  Ellagic acid can anchor rigorous casein kinase 2 studies when biochemical potency, solubility, cellular context, and orthogonal controls are interpreted together. This guide connects CK2 assay design with lessons from machine-learning senolytic discovery without overstating ellagic acid as a senolytic.

• Ziprasidone Augmentation in Anxious Depression

  2026-08-18

  This post-hoc analysis examined whether baseline anxiety altered the antidepressant or anxiolytic response to ziprasidone added to escitalopram. The augmentation strategy improved depressive symptoms similarly in patients with and without anxious depression, while the apparent anxiety benefit in patients with greater anxiety was not clinically meaningful.

• FGF–Shh Control of Penile Development Across Species

  2026-08-18

  A 2025 Cells study identifies differential Shh, Fgf10, and Fgfr2 expression as a major explanation for why guinea pigs form an open urethral groove whereas mice do not. By combining comparative developmental profiling with ex vivo pathway perturbation, the work provides a useful framework for interpreting species-specific genital morphogenesis and the limits of mouse models.

• HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody

  2026-08-17

  HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody supports bright, flexible detection of human IgG across immunofluorescence, Western blotting, flow cytometry, tissue staining, and ELISA. Its main use-case advantage is a direct fluorescent readout for human-serum and cell-based assays, while careful host-species matching keeps vaccine studies analytically valid.

• Anlotinib Hydrochloride in Angiogenesis Assays

  2026-08-17

  Anlotinib hydrochloride provides a practical way to connect receptor-level signaling with endothelial migration, tube formation, and tumor-vascularization readouts. This workflow-focused guide explains assay setup, concentration selection, comparative benchmarking, and troubleshooting for reproducible cancer research.

• EZ Cap™ Cre mRNA (m1Ψ): A Decision Guide

  2026-08-16

  This decision-focused guide explains how EZ Cap™ Cre mRNA (m1Ψ) converts transient mRNA expression into interpretable Cre/loxP experiments. It connects cap chemistry, mRNA handling, delivery design, and extrahepatic assay decisions without conflating carrier performance with recombinase performance.

• Tropisetron: From Receptor Tool to Translational Probe

  2026-08-15

  Tropisetron Hydrochloride is more than a selective 5-HT3 receptor antagonist: its dual receptor profile and emerging OCT2/MATE1 interaction data make it a useful translational probe. This article connects receptor pharmacology, transporter biology, assay design, and practical decision-making for researchers developing mechanistic and pharmacokinetic hypotheses.

7769 records 1/518 page Next 12345 下5页 Last page